OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis

Renal Failure

Volumn 35, Issue 6, 2013, Pages 825-829

  Tugcu, Volkan ^a   Simsek, Abdulmuttalip ^a   Tarhan, Tugba ^b   Atalar, Fatmahan ^c   Bitkin, Alper ^a   Tasci, Ali Ihsan ^a   Kural, Ali Riza ^d   Altug, Tuncay ^c  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Istanbul Acibadem Maslak Hospital   (Turkey)

Author keywords

Calcium oxalate; Osteopontin; Single nucleotide polymorphisms (SNPs); Urolithiasis

Indexed keywords

GENOMIC DNA; OSTEOPONTIN;

ADULT; ARTICLE; BODY MASS; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UROLITHIASIS; X RAY DIFFRACTION;

ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY; UROLITHIASIS;

EID: 84879006460     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.794431     Document Type: Article

References (25)

1. Vezolli G, Soldati L, Gambaro G. Update on primary hypercalciuria from a genetic perspective. J Urol. 2008;179:1676-1682
2. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin-A molecule for all seasons. Q J Med. 2002; 95:3-13 (Pubitemid 34173287)
3. Lieske JC, Leonard R, Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol. 1995;268:604-612
4. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JL. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998;53:194-199 (Pubitemid 28066921)
5. Worcester EM, Beshensky AM. Osteopontin inhibits nucleation of calcium oxalate crystals. Ann NY Acad Sci. 1995;760:375-377
6. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. Flexible structures of SIBLING proteins, bone sialoprotein and osteopontin. Biochem Biophys Res Commun. 2001;280:460-465 (Pubitemid 32912812)
7. Bid HK, Kumar A, Kapoor R, Mittal RD. Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. J Endourol. 2005;19:111-115 (Pubitemid 40365756)
8. Chen WC, Wu HC, Lu HF, Chen HY, Tsai FJ. Calcitonin receptor gene polymorphism: A possible genetic marker for patients with calcium oxalate stones. Eur Urol. 2001;39:716-719
9. Mittal RD, Bid HK, Manchanda PK. Genotype and haplotype determination of IL1B (g. -511C4T and g. 3954C4T) and (IL1RN) in pediatric nephrolithiasis. Clin Chim Acta. 2007; 379:42-47 (Pubitemid 46366965)
10. Ozturk M, Kordan Y, Cangul H, et al. Association of urokinase gene 30-UTR T/C polymorphism with calcium oxalate urolithiasis in children. Int Urol Nephrol. 2008;40:563-568
11. Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC. Association of E-cadherin gene 30-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int. 2003;70:278-281
12. Tugcu V, Ozbek E, Aras B, Arisan S, Cukurlu T, Tasci AI. Manganese superoxide dismutase (Mn-SOD) gene polymorphisms in urolithiasis. Uro Res. 2007;35:219-224
13. Yamate T, Tsuji H, Amasaki N, Iguchi M, Kurita T, Kohri K. Analysis of osteopontin DNA in patients with urolithiasis. Urol Res. 2000;28:159-166 (Pubitemid 30435675)
14. Gao B, Yasuti T, Tozawa K, Hayashi Y, Kohri K. A polymorphism of the osteopontin gene is related to urine calcium stones. J Urol. 2005;174:1472-1476 (Pubitemid 41318768)
15. Liu CC, Huang SP, Wu WJ, et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta. 2010;411:739-743
16. Kikuchi K, Tanaka A, Miyakawa H, Kawashima Y, Kawaguchi N, Matsushita M. Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis. Hepatol Res. 2003;26:87-90 (Pubitemid 36927177)
17. Xu AP, Bai J, Lu J, Liang YY, Li JG, Lai DY. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients. Chin Med J (Engl). 2007;120: 2124-2128 (Pubitemid 350268161)
18. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res. 1992;7:1029-1036
19. Lee MK, Kim TH, Lee SY, et al. Eta-1/osteopontin genetic polymorphism is associated with urolithiasis in Koreans. Korean J Urol. 2008;49:55-59 (Pubitemid 351227822)
20. Gao B, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. A polymorphism of the osteopontin gene is related to urinary calcium stones. J Urol. 2005;174:1472-1476 (Pubitemid 41318768)
21. Gao B, Yasui T, Itoh Y, et al. Association of osteopontin gene haplotypes with neprolithiasis. Kidney Int. 2007;72:592-598 (Pubitemid 47312789)
22. Giacopelli F, Marciano R, Pistorio A, et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics. 2004;20:87-96
23. Hummelshoj T, Ryder LP, Madsen HO, Odum N, Svejgaard A. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol Immunol. 2006;43:980-986 (Pubitemid 41814415)
24. Liu CC, Huang SP, Tsai LY, et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta. 2010;411:739-743
25. Gogebakan B, Igci ZY, Arslan A, et al. Association between the T593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis. Arc Med Res. 2010;41:442-448